Risk factors for multi-drug resistant acinetobacter baumannii nosocomial infection

Journal of the Medical Association of Thailand

Volumn 90, Issue 8, 2007, Pages 1633-1639

  Surasarang, Kunlayanee ^a   Narksawat, Kulaya ^b,c   Danchaivijitr, Somwang ^a   Siripanichgon, Kanokrat ^b   Sujirarat, Dusit ^b   Rongrungrueng, Yong ^a   Kiratisin, Pattarachai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Faculty of Public Health

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acinetobacter baumannii; Multidrug resistant; Nosocomial infection; Risk factors

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN; NETILMICIN; SULPERAZON;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CATHETERIZATION; CONTROLLED STUDY; HEALTH EDUCATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PATIENT CARE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; URINARY TRACT INFECTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34548675561     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9: 148-65.
2. Malatham K. Acinetobacter spp.: microbiology, epidemiology and antimicrobial resistance. In: Aswapokee N, Buppanharan W, Korbwattanakul S, Anekthananon T, editors. Emerging and re-emerging infections III. Bangkok: Holistic Publishing; 2002: 139-66.
3. rd ed. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins; 2004: 1613-36.
4. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11: 868-73.
5. Jain R, Danziger LH. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 2004; 38: 1449-59.
6. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-85.
7. Health Protection Agency (HPA). Acinetobacter spp. bacteraemia, England, Wales and Northern Ireland: CDR Wkly 2004 [cited 18 November 2004]; 14 (47). Available at: www.hpa.org.uk/cdr/archives/2004/bact_Acin_4704.pdf. Accessed 10 Aug 2005.
8. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41: 848-54.
9. Livermore DM. The threat from the pink corner. Ann Med 2003; 35: 226-34.
10. National Antimicrobial Resistance Surveillance Center Thailand. Antibiogram 1998. Available at: http://narst.dmsc.moph.go.th/ars/box/anti98. html; Accessed 10 Aug 2005.
11. National Antimicrobial Resistance Surveillance Center Thailand. Percentage of susceptible bacteria, 32 Hospitals,Jan-Dec 2003. Available at: http://narst.dmsc.moph.go.th/ars/box/anti2003.pdf. Accessed 10 Aug 2005.
12. Danchaivijitrmd S, Dhiraputra C, Santiprasitkul S, Judaeng T. Prevalence and impacts of nosocomial infection in Thailand 2001. J Med Assoc Thai 2005; 88(Suppl 10): S1-9.
13. Wilson SJ, Knipe CJ, Zieger MJ, Gabehart KM, Goodman JE, Volk HM, et al. Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am J Infect Control 2004; 32: 342-4.
14. th ed. New York: Lippincott-Raven; 1998: 215-36.
15. Lee SO, Kim NJ, Choi SH, Hyong KT, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004; 48: 224-8.
16. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A, Marquez-Vacaro JA, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 2005; 31: 649-55.
17. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005; 11: 22-9.
18. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Perez-Paredes C, Barrero-Almodovar AE, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 2001; 33: 939-46.